Avita Medical (RCEL) Stock Analysis & Winston Score
Avita Medical is a medical device company that makes a skin regeneration system called RECELL. The RECELL system lets doctors take a small patch of a patient's own skin and turn it into a spray that can cover large burn wounds. The main customers are hospitals and burn centers, primarily in the United States. Avita makes money by selling the RECELL device and the single-use kits that go with each procedure — a classic razor-and-blades model. The company operates mainly in the US, with some international presence, and its gross margins are strong at over 80%, reflecting the high value of its proprietary technology. However, Avita is still losing money at the operating level, spending heavily on sales, marketing, and expanding RECELL's approved uses beyond burns into areas like soft tissue repair and vitiligo — and whether those new indications gain traction with surgeons will be the key factor in determining if the company can reach profitability.
Winston Score: 0/100 — Insufficient Data
Not enough data to score this stock reliably.
- Quality: Mixed (10/30)
- Growth: Mixed (6/20)
- Cash Flow: Weak (0/10)
- Stability: Data not available (0/10)
- Valuation: Data not available (0/10)
- Ownership: Mixed (6/15)
Key Facts
Price: $10.06
Market Cap: $250M
Sector: Healthcare
Industry: Medical - Devices
Exchange: NASDAQ

